ArticleJAMA pediatrics2023

Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.

Bhagwat Gunale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.